: RNA samples sequenced in this study. RIN, RNA integrity number; F, female; M, male. Table S5 : Significant differentially expressed genes (Fold change ≥2, ≤-2) common to both cerebral palsy cases compared to in-house and gEUVADIS control data sets and cerebral palsy cases compared to in-house control samples regressed for age. Differential expression analysis was performed using the EdgeR package from Bioconductor. Right panel is all samples, including the 100 gEUVADIS data set controls. B) Age profile at time of sampling for samples from this study. In-house controls are the 20 control samples used in RNA sequencing, while the 'Aussie Normals' collection controls were used for quantitative RT PCR validation of select differentially expressed genes. C) Relative log expression of transcripts in each sample following data normalisation and batch correction using ComBat function from the SVA package in R. Green samples are those sequenced in this study, while orange samples are samples sequenced as part of the gEUVADIS data set. D) Multidimensional scaling plots for all samples before (left) and after (right) gender effects were blocked and batch effects removed using the ComBat function. CP cases are in red and controls are in blue, with triangles for samples sequenced in this study and circles for samples from the gEUVADIS data set. 
